Jennifer Lord, M Mateo Paz Soldan, Jonathan Galli, Karen L Salzman, Jacob Kresser, Rae Bacharach, L Dana DeWitt, Julia Klein, John Rose, John Greenlee, Stacey L Clardy
OBJECTIVE: To characterize patients with neurosarcoidosis within the University of Utah healthcare system, including demographics, clinical characteristics, treatment, and long-term outcomes. METHODS: We describe the clinical features and outcomes of patients with neurosarcoidosis within the University of Utah healthcare system (a large referral center for 10% of the continental United States by land mass). Patients were selected who met the following criteria: (1) at least one International Classification of Diseases Clinical Modification , 9th revision code 135 or International Classification of Diseases Clinical Modification , 10th revision code D86* (sarcoidosis) and (2) at least one outpatient visit with a University of Utah clinician in the Neurology Department within the University of Utah electronic health record...
July 2020: Neurology® Neuroimmunology & Neuroinflammation